Argininosuccinic acid
|
Basic information |
| Metabolite name | Argininosuccinic acid |
 | HMDB0000052 |
 |
C03406 |
 |
16950 |
| Synonyms | Argininosuccinate; |
| No. of studies | 5 |
|
Basic information |
| Metabolite name | Argininosuccinic acid |
| HMDB0000052 |
|
C03406 |
|
16950 |
| Synonyms | Argininosuccinate; |
| No. of studies | 5 |
|
Relationship between Argininosuccinic acid and depression (count: 5) |
| Study | Study Type  |
Comparison groups | Tissue | Organism | Up/Down regulated |
| Study M033 | Type3 | paroxetine group vs. control group | Hippocampus | DBA/2OlaHsd mouse | Up |
| Study M050 | Type3 | 2h Ketamine group vs. control group | Hippocampus | C57BL/6 mouse | Down |
| Study M648 | Type1 | ART-treated HIV with depressive symptom group vs. ART-treated HIV without depressive symptom group, discovery cohort | Plasma | Human | Up |
| Study M748 | Type1 | short-day group vs. long-day group | Plasma | C57BL/6 J mouse | Down |
| Study M786 | Type4 | responder group vs. non-responder group, at baseline | Faece | Human | Down |